1. Volume 78, Issue 10, Pages 1033-1040 (November 2010)
Urinary granzyme A mRNA is a biomarker to diagnose subclinical and acute cellular rejection in kidney transplant recipients 
S. Marieke van Ham, Kirstin M. Heutinck, Tineke Jorritsma, Fréderike J. Bemelman, Merel C.M. Strik, Wim Vos, Jettie J.F. Muris, Sandrine Florquin, Ineke J.M. ten Berge, Ajda T. Rowshani 
Kidney International 
Volume 78, Issue 10, Pages (November 2010)
DOI: /ki
Copyright © 2010 International Society of Nephrology Terms and Conditions

2. Figure 1
Urinary granzyme A (GzmA) mRNA expression correlates with subclinical rejection and acute T-cell-mediated rejection (TCMR). Urine samples were collected from recipients with stable graft function (stable, n=10), acute tubular necrosis (ATN, n=9), subclinical rejection (SCR, n=10), and TCMR type I (TCMR-I, n=20). Transcription levels of GzmA, granzyme B (GzmB), perforin, and SerpinB9 were analyzed as described in Materials and Methods section. Horizontal lines represent medians, and asterisks refer to a significant difference (Mann–Whitney, P<0.02 after correction for multiple testing). (a) GzmA mRNA is significantly elevated in urine of both SCR and TCMR-I compared to stable graft function and ATN. (b) GzmB is significantly elevated during TCMR-I compared to stable and ATN. Despite a trend towards higher levels, GzmB is not significantly elevated during SCR compared to stable and ATN. (c) Perforin transcripts are measurable in all groups tested. Perforin levels are significantly increased during subclinical rejection (SCR) and TCMR-I as compared with stable. (d) SerpinB9 mRNA is commonly present in urine of transplant patients at high levels (note the high upper rank depicted on the y axis) and does not differ significantly between different groups. Transcription of this gene is significantly induced during TCMR-I compared with stable patients.
Kidney International  , DOI: ( /ki )
Copyright © 2010 International Society of Nephrology Terms and Conditions

3. Figure 2
Urinary granzyme A (GzmA) mRNA is a sensitive and highly specific diagnostic biomarker to distinguish subclinical and acute cellular rejection from stable graft function and acute tubular necrosis. (a) The graphs represent receiver operating characteristic (ROC) curves visualizing the proportion of true negative results (sensitivity) and true-positive results (specificity) using urinary mRNA levels to discriminate between subclinical rejection (SCR) or T-cell-mediated rejection type I (TCMR-I) from respectively stable or acute tubular necrosis (ATN). An area under the curve value of 0.5 is no better than expected by chance; a value of 1.0 reflects a perfect marker. The upper row of ROC curves represents GzmA mRNA followed downwards by GzmB, perforin, and SerpinB9. GzmA is the most powerful diagnostic biomarker to distinguish both types of rejection from stable and ATN as visualized by a high sensitivity and specificity (see Supplementary Table S4 for accuracy characteristics). (b) The value of GzmA and GzmB mRNA levels in differentiating SCR or TCMR-I from stable graft function and ATN is visualized in 2 × 2 contingency tables. The data represent the number of patients with, respectively, a true-positive, false-positive, true-negative, or false-negative diagnosis of rejection based on urinary mRNA levels, as compared with biopsy findings; the reference standard. The best cut-off points were based on the ROC curve with preference for high specificity.
Kidney International  , DOI: ( /ki )
Copyright © 2010 International Society of Nephrology Terms and Conditions

4. Figure 3
Expression and colocalization of granzyme A (GzmA), granzyme B (GzmB) by graft infiltrating T cells and natural killer cells during rejection. Triple immunohistochemical stainings were performed to identify the source of GzmA and GzmB during renal allograft rejection. Depicted is a biopsy with TCMR-I showing triple staining with CD3 (blue), GzmA (green), GzmB (red), nuclear counterstaining (gray), and overlay. Many graft infiltrating cells are CD3-positive T cells containing granzymes, for example, the triple positive cells located inside a tubulus and in the interstitium (white arrows). Granzyme-double positive, CD3-negative cells were also present at a lower frequency, for example, the cell at the upper left. The intensity and ratio of GzmA and GzmB differed per cell.
Kidney International  , DOI: ( /ki )
Copyright © 2010 International Society of Nephrology Terms and Conditions